XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Gross premiums written $ 3,990,684 $ 2,790,261
Net premiums written 3,199,573 2,263,703
Decrease (increase) in unearned premiums (755,663) (583,153)
Net premiums earned 2,443,910 1,680,550
Net investment income 390,775 254,378
Net foreign exchange gains (losses) (35,683) (14,503)
Equity in earnings (losses) of other ventures 14,127 9,530
Other income (loss) (50) (4,306)
Net realized and unrealized gains (losses) on investments (213,654) 279,451
Total revenues 2,599,425 2,205,100
Expenses    
Net claims and claim expenses incurred 1,166,123 801,200
Acquisition expenses 630,921 432,257
Operational expenses 106,184 77,474
Corporate expenses 39,252 12,843
Interest expense 23,104 12,134
Total expenses 1,965,584 1,335,908
Income (loss) before taxes 633,841 869,192
Income tax benefit (expense) (15,372) (28,902)
Net income (loss) 618,469 840,290
Net (income) loss attributable to redeemable noncontrolling interests (244,827) (267,384)
Net income (loss) attributable to RenaissanceRe 373,642 572,906
Dividends on preference shares (8,844) (8,844)
Net income (loss) available (attributable) to RenaissanceRe common shareholders $ 364,798 $ 564,062
Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) $ 6.96 $ 12.95
Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) $ 6.94 $ 12.91